Session 4: Microbes and Alzheimer's Disease: Bridging Silos to Accelerate Innovation Symposium 2024

Session 4 begins with an awesome presentation by Dr. Lavinia Alberi, a neuroscientist, innovator and salivary diagnostic expert. She shares insights on saliva markers as a novel diagnostic for Alzheimer's. Dr. Michael Detke of Lighthouse Pharmaceuticals gives a presentation on their new chemical entity targeting (LTE-588) Porphyromonas gingivalis and gingipains for patients with mild to moderate Alzheimer's Disease. Finally, retired Fighter Pilot Colonel Nicole Malachowski delivers an incredibly motivating and emotional Keynote presentation of her journey to become the first female Thunderbird Pilot in history plus her harrowing journey to heal from late-stage tick-borne infections.